Safilo Group S.p.A. (SAFLF)
USD 0.98
(0.0%)
USD 0.98
(0.0%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 56.35 Million EUR | -38.69% |
| 2022 | 89.46 Million EUR | 28.05% |
| 2021 | 69.87 Million EUR | 293.05% |
| 2020 | -16.27 Million EUR | 76.66% |
| 2019 | -155.06 Million EUR | -351.74% |
| 2018 | 11.45 Million EUR | 139.31% |
| 2017 | -156.68 Million EUR | -171.59% |
| 2016 | -57.69 Million EUR | -236.18% |
| 2015 | 42.36 Million EUR | -57.87% |
| 2014 | 110.49 Million EUR | -9.01% |
| 2013 | 110.5 Million EUR | -2.27% |
| 2012 | 106.27 Million EUR | -3.49% |
| 2011 | 112.32 Million EUR | 7.93% |
| 2010 | 108.34 Million EUR | 64.39% |
| 2009 | -220.79 Million EUR | -48.08% |
| 2008 | 127.18 Million EUR | -28.16% |
| 2007 | 177.02 Million EUR | 9.98% |
| 2006 | 154.96 Million EUR | 10.96% |
| 2005 | 135.09 Million EUR | 30.37% |
| 2004 | 111.27 Million EUR | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q2 | 61.06 Million USD | 0.0% |
| 2023 FY | - EUR | -38.69% |
| 2023 Q4 | 21.29 Million USD | 42.4% |
| 2023 Q3 | 14.95 Million EUR | -74.98% |
| 2023 Q2 | 59.77 Million USD | 125.52% |
| 2023 Q1 | 26.5 Million EUR | -31.41% |
| 2022 Q2 | 28.88 Million USD | 0.0% |
| 2022 Q4 | 38.64 Million USD | 240.05% |
| 2022 FY | - EUR | 28.05% |
| 2022 Q1 | 28.88 Million EUR | 179.11% |
| 2022 Q3 | 11.36 Million EUR | -60.66% |
| 2021 Q3 | 10.35 Million EUR | -57.26% |
| 2021 Q2 | 24.21 Million USD | 0.0% |
| 2021 FY | - EUR | 293.05% |
| 2021 Q1 | 24.21 Million EUR | 164.93% |
| 2021 Q4 | 10.35 Million USD | 0.0% |
| 2020 Q3 | 9.14 Million EUR | 144.66% |
| 2020 FY | - EUR | 76.66% |
| 2020 Q1 | -20.46 Million EUR | -255.76% |
| 2020 Q2 | -20.46 Million USD | 0.0% |
| 2020 Q4 | 9.14 Million USD | 0.0% |
| 2019 Q3 | 13.14 Million EUR | -75.49% |
| 2019 Q1 | 17.32 Million EUR | 4671.63% |
| 2019 FY | - EUR | -351.74% |
| 2019 Q2 | 53.61 Million EUR | 209.53% |
| 2019 Q4 | 13.14 Million USD | 0.0% |
| 2018 Q3 | 363 Thousand EUR | -93.23% |
| 2018 Q4 | 363 Thousand EUR | 0.0% |
| 2018 FY | - EUR | 139.31% |
| 2018 Q1 | 5.36 Million EUR | 183.03% |
| 2018 Q2 | 5.36 Million EUR | 0.0% |
| 2017 Q1 | 919.5 Thousand EUR | -87.09% |
| 2017 Q4 | -6.46 Million EUR | 0.0% |
| 2017 Q3 | -6.46 Million EUR | -802.56% |
| 2017 FY | - EUR | -171.59% |
| 2017 Q2 | 919.5 Thousand EUR | 0.0% |
| 2016 FY | - EUR | -236.18% |
| 2016 Q2 | 29.72 Million EUR | 0.0% |
| 2016 Q4 | 7.12 Million EUR | 0.0% |
| 2016 Q3 | 7.12 Million EUR | -76.05% |
| 2016 Q1 | 29.72 Million EUR | 269.8% |
| 2015 FY | - EUR | -57.87% |
| 2015 Q4 | -17.5 Million EUR | -244.69% |
| 2015 Q3 | 12.1 Million EUR | -57.79% |
| 2015 Q2 | 28.66 Million EUR | 39.95% |
| 2015 Q1 | 20.48 Million EUR | -9.0% |
| 2014 Q1 | 35.08 Million EUR | 24.63% |
| 2014 Q4 | 22.5 Million EUR | 179.48% |
| 2014 Q3 | 8.05 Million EUR | -77.65% |
| 2014 Q2 | 36.03 Million EUR | 2.71% |
| 2014 FY | - EUR | -9.01% |
| 2013 FY | - EUR | -2.27% |
| 2013 Q2 | 32.03 Million EUR | -7.21% |
| 2013 Q4 | 28.14 Million EUR | 76.86% |
| 2013 Q1 | 34.52 Million EUR | 69.55% |
| 2013 Q3 | 15.91 Million EUR | -50.32% |
| 2012 Q1 | 33.26 Million EUR | 35.13% |
| 2012 Q3 | 15.13 Million EUR | -56.8% |
| 2012 Q4 | 20.36 Million EUR | 34.53% |
| 2012 FY | - EUR | -3.49% |
| 2012 Q2 | 35.04 Million EUR | 5.34% |
| 2011 Q2 | 341.43 Million EUR | 733.67% |
| 2011 Q4 | 24.61 Million EUR | 41.15% |
| 2011 FY | - EUR | 7.93% |
| 2011 Q3 | 17.44 Million EUR | -94.89% |
| 2011 Q1 | 40.95 Million EUR | 60.51% |
| 2010 Q2 | 30.2 Million EUR | -12.79% |
| 2010 FY | - EUR | 64.39% |
| 2010 Q3 | 17.72 Million EUR | -41.33% |
| 2010 Q1 | 34.63 Million EUR | 210.82% |
| 2010 Q4 | 25.51 Million EUR | 43.98% |
| 2009 Q1 | 30.21 Million EUR | 0.0% |
| 2009 FY | - EUR | -48.08% |
| 2009 Q4 | 11.14 Million EUR | 196.3% |
| 2009 Q3 | 3.76 Million EUR | -82.01% |
| 2009 Q2 | 20.9 Million EUR | -30.82% |
| 2008 FY | - EUR | -28.16% |
| 2007 FY | - EUR | 9.98% |
| 2006 FY | - EUR | 10.96% |
| 2005 FY | - EUR | 30.37% |
| 2004 FY | - EUR | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| American Medical Technologies Inc. | -963.95 Thousand USD | 5945.922% |
| Ansell Limited | 209.86 Million USD | 73.148% |
| Ansell Limited | 206.3 Million USD | 72.684% |
| BG Medicine, Inc. | - USD | -Infinity% |
| Biotage AB (publ) | 42.83 Million USD | -31.541% |
| BioLife Sciences Inc. | - USD | -Infinity% |
| CB Scientific, Inc. | -1.62 Million USD | 3567.92% |
| Psykey, Inc. | -1.29 Million USD | 4450.485% |
| ConvaTec Group Plc | 455.5 Million USD | 87.629% |
| ConvaTec Group Plc | 455.5 Million USD | 87.629% |
| Encision Inc. | -544.19 Thousand USD | 10455.112% |
| Golden Valley Development, Inc | -141.81 Thousand USD | 39837.677% |
| Hear AtLast Holdings, Inc. | -109.93 Thousand USD | 51361.712% |
| Innovative MedTech Inc. | -7.67 Million USD | 834.341% |
| LifePoint, Inc. | -14.2 Million USD | 496.785% |
| Medite Cancer Diagnostics, Inc. | -6.18 Million USD | 1010.813% |
| Paradigm Medical Industries, Inc. | -325 Thousand USD | 17439.077% |
| QuantRx Biomedical Corporation | - USD | -Infinity% |
| Remedent, Inc. | -215.23 Thousand USD | 26281.737% |
| Reflect Scientific, Inc. | -405.78 Thousand USD | 13987.191% |
| SmileDirectClub, Inc. | -186.13 Million USD | 130.274% |
| Sector 10, Inc. | - USD | -Infinity% |
| Shandong Weigao Group Medical Polymer Company Limited | 447.82 Million USD | 87.416% |
| SheerVision, Inc. | -110.53 Thousand USD | 51082.982% |
| United Health Products, Inc. | -2.5 Million USD | 2352.086% |
| Vasamed, Inc. | -4.57 Million USD | 1331.888% |
| Wearable Health Solutions, Inc. | -2.26 Million USD | 2592.64% |
| Yubo International Biotech Limited | -1.17 Million USD | 4884.977% |